KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814 ~ Phase 2b dose range finding study showed rapid and highly significant [...]
In December (3rd-4th, 2019) 150 leaders in women’s health will be coming together in Boston at the Women’s Health Innovation Summit to drive innovation at the convergence of technology and [...]
Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the 25th Annual BIO-Europe Conference During the BIO-Europe conference taking place from 11-13 November in Hamburg, Dr Mary Kerr will be [...]
Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the SVB Leerink New Treatments Focused on Women’s Health Conference, New York On the 10 October, Dr Mary Kerr will be attending and [...]
Launched in 2017, KaNDy Therapeutics is a UK based clinical-stage company focused on optimizing the potential of its unique NK-1,3 receptor antagonist NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions.
We are using cookies to give you the best experience on our website.
You can find out more about which cookies we are using or switch them off in settings.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy